CNTB
Connect Biopharma Holdings Limited
Biotechnology · Healthcare · United States
0.80
close · 2026-10-30
value
6
cheaper than peers6
quality
63
stronger fundamentals63
ranked against
Biotechnology (commercial)
value
quality
162 peerswide variation
Value inputs
| measure | company | vs peers |
| price to book | 1.88× | 72 |
| price to sales | 17.11× | 40 |
| earnings yield, 1 year ago | -34.9% | 34 |
| cash flow yield, 1 year ago | -48.2% | 18 |
| earnings yield, 2 years ago | -140.9% | 12 |
| cash flow yield, 2 years ago | -94.7% | 11 |
| cash flow yield, latest year | -102.2% | 9 |
| earnings yield, latest year | -124.7% | 7 |
| earnings yield, 3 years ago | -268.0% | 7 |
| cash flow yield, 3 years ago | -209.7% | 7 |
10 of 12 measures available
Quality inputs
| measure | company | vs peers |
| revenue growth | 5666.7% | 97 |
| debt to equity | 2.2% | 85 |
| operating margin | -636.0% | 29 |
| return on equity | -140.5% | 17 |
4 of 4 measures available
Facts
| market cap | $51M |
| free cash flow | -$34.7M |
| employees | 64 |
| first trade | 2021-03-19 |
| next earnings | not reported |
| fundamentals updated | 2026-08-14 |
Annual history
| measure | 2025 | 2024 | 2023 | 2022 | 2021 |
| diluted eps | -1.00 | -0.28 | -1.13 | -2.15 | not reported |
| free cash flow | -$51.6M | -$24.4M | -$47.8M | -$105.9M | not reported |
| net income | -$55.5M | -$15.6M | -$62.1M | -$118.1M | not reported |
| revenue | $64,000 | $26.0M | $0 | $0 | not reported |
| unusual items | not reported | not reported | $2.9M | -$3.0M | -$104.4M |